Abstract
Bariatric surgery is recognized worldwide as a cost-effective treatment for morbidly obese patients. In recent years, the role of these procedures has been revised following the impressive postoperative outcomes from a metabolic and functional viewpoint. These outcomes have given rise to further possible indications for bariatric procedures that could be applied to non-obese patients in the near future. This chapter summarizes the evidence collected following bariatric procedures, both in terms of weight loss and remission of co-morbidities. We still need to clarify the concepts of “ideal weight” and “success” in bariatric surgery and moreover the exact interaction between gut hormones, pancreatic endocrine function and adipose cell signaling needs further investigations to predict a possible outcome or a possible relapse of a metabolic condition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hippocrates. Hippocrates (trans: Jones WHS). London/Cambridge: William Heinemann LTD/Harvard University Press; 1923.
Galeni C, Kalbfleisch K. Galeni De victu attenuante liber. Greek, Ancient [to 1453]. Lipsiae: In Aedibus B.G. Teubneri; 1898.
Alighieri D. The divine comedy, Canticle 6, third circle, The Gluttonous (trans: Longfellow HW). New York: Random House Publishing Group; 2003.
Moshiri M, Osman S, Robinson TJ, Khandelwal S, Bhargava P, Rohrmann CA. Evolution of bariatric surgery: a historical perspective. AJR Am J Roentgenol. 2013;201(1):W40–8.
Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H et al.; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
Shah B, Sucher K, Hollenbeck CB. Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States. Nutr Clin Pract. 2006;21(3):312–9.
Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17(7):565–8.
Reinhold RB. Critical analysis of long term weight loss following gastric bypass. Surg Gynecol Obstet. 1982;155(3):385–94.
Christou NV, Look D, McLean LD. Weight gain after short and long limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40.
O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94.
Pérez-Romero N, Serra A, Granada ML, Rull M, Alastrué A, Navarro-Díaz M, et al. Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up. Obes Surg. 2010;20(5):600–9.
Mason EE. Surgical treatment of obesity. Major Probl Clin Surg. 1981;26:26–480.
Mason EE, Culen JJ. Management of complications in vertical banded gastroplasty. Curr Probl Surg. 1997;7:359–62.
Melissas J, Leventi A, Klinaki I, Perisinakis K, Koukouraki S, de Bree E, et al. Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study. Ann Surg. 2013;258(6):976–82.
Ma X, Lin L, Yue J, Pradhan G, Qin G, Minze LJ, et al. Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutr Diabetes. 2013;3, e99.
Clinical Issues Committee ASMBS. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2012;8(3):e21–6.
Aurora AR, Khaitan L, Saber AA. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc. 2012;26(6):1509–15.
Gagner M, Buchwald JN. Comparison of laparoscopic sleeve gastrectomy leak rates in four staple line reinforcement options: a systematic review. Surg Obes Relat Dis. 2014;10(4):713–23.
Van de Vrande S, Himpens J, El Mourad H, et al. Management of chronic proximal fistulas after sleeve gastrectomy by laparoscopic Roux limb placement. Surg Obes Relat Dis. 2013;9(6):856–61.
Burgerhart JS, Schotborgh CA, Schoon EJ, et al. Effect of sleeve gastrectomy on gastroesophageal reflux. Obes Surg. 2014;24(9):1436–41.
Mahawar KK, Jennings N, Balupuri S, et al. Sleeve gastrectomy and gastro-oesophageal reflux: a complex relationship. Obes Surg. 2013;23(7):987–91.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases.Obes Surg. 2001;11(3):276–80.
Lee WJ, Yu PJ, Wang W, Chen TC, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20–8.
Sudan R, Jacobs DO. Biliopancreatic diversion with duodenal switch. Surg Clin North Am. 2011;91(6):1281–93.
Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.
Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond). 2008;32 Suppl 7:S93–7.
Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013;36(1):20–6.
Yang J, Feng X, Zhong S, Wang Y, Liu J. Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI ≥32.5 kg/m2. Obes Surg. 2014;24(4):561–71.
Kario K. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure. Hypertens Res. 2009;32(6):428–32.
Krieger D, Landsberg L. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Am J Hypertens. 1988;1(1):84–90.
Karaca Ü, Schram MT, Houben AJ, Muris DM, Stehouwer CD. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. Diab Res Clin Pract. 2014;103(3):382–7.
Karlsson J, Sjöström L, Sullivan M. Swedish obese subjects (SOS)—an intervention study of obesity. Two-year follow-up of health related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes (Lond). 1998;22(2):113–26.
The global challenge of obesity and the international obesity task force [Internet]. 2012. [Updated 2014 July 25; cited]. Available from: http://www.iuns.org/the-global-challenge-of-obesity-and-the-international-obesity-task-force.
Quality and outcomes framework (QOF) 2011 [Internet]. 2011 [cited]. Available from: England: http://bit.ly/qof2011e,Northern Ireland: http://bit.ly/qof2011ni, Scotland: http://bit.ly/qof2011s, Wales: http://bit.ly/qof2011w.
Khwaja HA, Brethauer SA, Schauer PR. Bariatric surgery for type 2 diabetes mellitus. In: Murayama KM, Chand B, Kothari SN, Mikami D, Nagle A (eds) Evidence-based approach to minimally invasive surgery. CInt-Med. 2012.
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.e5.
Klein S, Ghosh A, Cremieux PY, Eapen S, McGavock TJ. Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m2. Obesity (Silver Spring). 2011;19(3):581–7.
Bolen SD, Chang HY, Weiner JP, Richards TM, Shore AD, Goodwin SM, et al. Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US states. Obes Surg. 2012;22(5):749–63.
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.
Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.
Carlsson LM, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.
Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.
Dixon JB, Zimmet P, Alberti KG, Rubino F; on behalf of the International Diabetes federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28(6):628–42.
American Diabetes Association. ASMBS Clinical Issues Committee. Bariatric surgery in class I obesity (BMI 30–35 kg/m2). Surg Obes Relat Dis 2013;9(1):e1–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Leuratti, L., Khwaja, H.A., Kerrigan, D.D. (2016). Evidence Base for Bariatric Surgery. In: Agrawal, S. (eds) Obesity, Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-04343-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-04343-2_7
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-04342-5
Online ISBN: 978-3-319-04343-2
eBook Packages: MedicineMedicine (R0)